SEC Form 4 · accession 0001209191-15-052731
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Hochman
Director
Period of report
Jun 12, 2015
Accepted (ET)
Jun 12, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 12, 2015 | M | 10,000 | $1.00 | A | 453,300 | D | |
| Common Stock | Jun 12, 2015 | M | 50,000 | $1.00 | A | 190,000 | I | By NSH 2008 Family Trust |
| Common StockF1 | holding | — | — | — | 4,300 | I | By Solomon Asher Hochman Trust of 2005 | |
| Common StockF1 | holding | — | — | — | 4,300 | I | By Hannah Hochman Trust of 2007 | |
| Common StockF1 | holding | — | — | — | 4,300 | I | By Judah Herman Hochman Trust of 2009 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $1.00 | Jun 12, 2015 | M | 10,000 | D | May 30, 2014 | May 30, 2019 | Common Stock | 10,000 | 0 | D |
| Warrant | $1.00 | Jun 12, 2015 | M | 50,000 | D | Apr 11, 2014 | Apr 11, 2019 | Common Stock | 50,000 | 0 | I |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934. as amended, or for any other purpose.